Clinical Trials at Oak Tree Surgery
During the past decade, Oak Tree Surgery conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Oak Tree Surgery" #1 sponsor was "Boehringer Ingelheim" with 1 trials, followed by "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials
sponsored, "Kowa Research Institute, Inc." with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oak Tree Surgery"
#1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Oak Tree Surgery
According to Clinical.Site data, the most researched conditions in "Oak Tree Surgery" are
"Atherosclerotic Cardiovascular Disease" (3 trials), "Familial Hypercholesterolemia" (2 trials), "Type2 Diabetes" (2 trials), "Cardiovascular Diseases" (1 trials) and "Clostridium Difficile Infection" (1 trials). Many other conditions were trialed in "Oak Tree Surgery" in a lesser frequency.
Clinical Trials Intervention Types at Oak Tree Surgery
Most popular intervention types in "Oak Tree Surgery" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "ALN-PCSSC" (1 trials), "Clostridium difficile vaccine" (1 trials), "Evolocumab" (1 trials) and "Inclisiran" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Oak Tree Surgery
The vast majority of trials in "Oak Tree Surgery" are
6 trials for "All" genders.
Clinical Trials Status at Oak Tree Surgery
Currently, there are NaN active trials in "Oak Tree Surgery".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Oak Tree Surgery,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Oak Tree Surgery, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".